Marjan van den Akker worked at the Maastricht University (Netherlands) and is an internationally recognised expert in the field of multimorbidity and polypharmacy. From 1st March, she will start projects to enhance medication prescriptions to patients with multimorbidity (co-occurring diseases) in cooperation with doctors, pharmacists, scientists and nurse practitioners. The chair has been endowed for a period of six years by INSIGHT Health, a company that specialises in the analysis of medical prescriptions.
"Older patients in particular, but younger patients as well, are affected by multimorbidity. They usually have a complex health situation that can be quite challenging for doctors," says Professor van den Akker. Her research focuses on frequent disease combinations and their medical treatment. She wants to improve the care for these patients by the further development and evaluation of interventions.
Previous studies have shown that for many patients with multimorbidity, overall prescriptions can be improved either by reducing medications, or sometimes by prescribing additional medication. "It's important to me to take the preferences and living circumstances of the patients into account. The benefits and risks of medication need to be discussed with their doctor, and a decision then reached together."
In view of the frequency and complexity of polypharmacy, Professor van den Akker desires to educate both medical and pharmaceutical students in caring for this patient group. She plans to set up an interdisciplinary teaching programme offering joint classes for future doctors and future pharmacists.
Prof. Ferdinand Gerlach, Director of the Institute of General Practice, is happy with the new chair. "The new endowed chair is a perfect fit for our research profile in Frankfurt. With Professor van Akker, we can develop new paths for improving health care for the chronically ill and support general practitioners in their important work even better."
Professor Pfeilschifter, Dean of the Faculty of Medicine, adds: "Medication research and medication therapy are a focal point of the Faculty of Medicine and of Goethe University overall. As such Professor van den Akker is an excellent choice and she complements the dynamic field of Medicine at Goethe University."
Further information: Prof. Dr. Marjan van den Akker, Institute of General Practice, Campus Niederrad, Tel.: +49 69 6301-80454/-5930; m.vandenAkker@allgemeinmedizin.uni-frankfurt.de
Current news about science, teaching, and society in GOETHE-UNI online
Goethe University is a research-oriented university in the European financial centre Frankfurt The university was founded in 1914 through private funding, primarily from Jewish sponsors, and has since produced pioneering achievements in the areas of social sciences, sociology and economics, medicine, quantum physics, brain research, and labour law. It gained a unique level of autonomy on 1 January 2008 by returning to its historic roots as a "foundation university". Today, it is one of the three largest universities in Germany. Together with the Technical University of Darmstadt and the University of Mainz, it acts as a partner of the inter-state strategic Rhine-Main University Alliance. Internet: http://www.uni-frankfurt.de
Publisher: The President of Goethe University Editor: Dr. Anne Hardy, Referee for Science Communication, PR & Communication Department, Theodor-W.-Adorno-Platz 1, 60323 Frankfurt am Main, Tel: (069) 798-13035, Fax: (069) 798-763 12531.